scispace - formally typeset
B

Bing Xu

Researcher at Brandeis University

Publications -  373
Citations -  29970

Bing Xu is an academic researcher from Brandeis University. The author has contributed to research in topics: Self-healing hydrogels & Cancer cell. The author has an hindex of 83, co-authored 357 publications receiving 26713 citations. Previous affiliations of Bing Xu include University of Pennsylvania & University of Hong Kong.

Papers
More filters
Journal ArticleDOI

Using enzymatic reactions to enhance the photodynamic therapy effect of porphyrin dityrosine phosphates

TL;DR: The synthesis and photodynamic therapy (PDT) effect of a porphyrin derivative containing tyrosine phosphate is reported, which promises a new, useful approach to develop PDT agents.
Journal ArticleDOI

L-Rhamnose-containing supramolecular nanofibrils as potential immunosuppressive materials

TL;DR: An l-rhamnose-based hydrogelator self-assembles to form nanofibrils, which suppress the antibody response of mice to phycoerythrin (PE), a fluorescent protein antigen.
Journal ArticleDOI

Enzyme-Instructed Self-Assembly of Peptides Containing Phosphoserine to Form Supramolecular Hydrogels as Potential Soft Biomaterials.

TL;DR: Exchanging the positions of phosphorylated serine and tyrosine in the peptide backbone provides insights on how the specific molecular structures influence self-assembling behaviors of small peptides and the subsequent cellular responses.
Journal ArticleDOI

Magnetic nanoparticles for direct protein sorting inside live cells

TL;DR: This work reports the first example of the biofunctional magnetic nanoparticles as a “magnetic dock” for directly sorting proteins inside live cells and may ultimately contribute to the exploration of the functions of proteins via the selective, spatiotemporal control of the proteins by a magnetic force.
Journal ArticleDOI

Trypsin-Instructed Self-Assembly on Endoplasmic Reticulum for Selectively Inhibiting Cancer Cells: Dedicated to Professor George M. Whitesides on the occasion of his 80th birthday.

TL;DR: An easily accessible branched peptide that consists of a D‐tetrapeptide backbone and a branch with the sequence of KYDKKKKDG, being an EISA substrate of typsin‐1 (PRSS1), selectively inhibits cancer cells is reported.